Pillar Biosciences pillar-biosciences.com


Pillar Biosciences leverages patent-pending targeted sequencing technology platform and a proprietary data analysis toolkit to provide a targeted sequencing method for NGS-based oncology testing.

Pillar Biosciences leverages patent-pending targeted sequencing technology platform and a proprietary data analysis toolkit to provide a targeted sequencing method for NGS-based oncology testing.

Company (Alive / Active)

Phone: 508-655-3027

Fax:

12 Michigan Drive

Natick, 01760
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Pillar Biosciences $18M May 11, 2016

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Pillar Biosciences Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Method for reducing primer-dimer amplification Jun 16, 2016 Mar 28, 2017 Patent
Selective amplification of overlapping amplicons Dec 30, 2016 Application
Selective amplification of overlapping amplicons Mar 01, 2016 Application